Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ticagrelor Versus Cilostazol in Moderate and Moderate-to-severe Ischemic Stroke, a Randomized Controlled Trial

NCT06561867 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT06561867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06561867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ticagrelor Versus Cilostazol in Moderate and Moderate-to-severe Ischemic Stroke, a Randomized Controlled Trial
Lead sponsor
Kafrelsheikh University
Phase
Phase 3
Overall status
Recruiting
Start date
August 30, 2024
Completion date
December 20, 2025
Enrollment
900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke